secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002707
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dianthus expects ~$173M cash at year-end 2023; to present at JPM conference
---------------------------------------------------------------------------

- Preliminary unaudited cash, equivalents, and short-term investments of ~$173M as of Dec 31, 2023.
- Audited FY2023 financials not yet available; actual results may differ materially.
- CEO Marino Garcia to present at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000095017024002707/0000950170-24-002707-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000095017024002707/dnth-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002707

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer